US 11931340
Use of sublingual dexmedetomidine for the treatment of agitation
granted A61KA61K31/4174A61K45/06
Quick answer
US patent 11931340 (Use of sublingual dexmedetomidine for the treatment of agitation) held by BioXcel Therapeutics, Inc. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioXcel Therapeutics, Inc.
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/4174, A61K45/06, A61K47/10, A61K9/006